Please login to the form below

Not currently logged in


This page shows the latest Spirogen news and features for those working in and with pharma, biotech and healthcare.

MedImmune partners with US National Cancer Institute

MedImmune partners with US National Cancer Institute

AZ boosted its pipeline in thsi area with the $440m acquisition of Spirogen.

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Pharma deals during October 2013 Pharma deals during October 2013

    Auven's portfolio of companies includes Resolvyx, Kiacta, Kolitan and Sprout Pharmaceuticals, as well as Spirogen and ADC Therapeutics. ... The Spirogen/Auven Therapeutics deal with MedImmune discussed above re-confirms that ADC technology is certainly

  • Deal Watch table for October 2013 Deal Watch table for October 2013

    730. Spirogen / MedImmune. Acquisition. ADC technology - oncology (lead asset in phase II).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Porterhouse Medical Group

Porterhouse Medical provides medical and scientific communication services to the pharmaceutical industry across the globe, with a focus on solutions...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...